<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00749307</url>
  </required_header>
  <id_info>
    <org_study_id>ALFAHRV01</org_study_id>
    <secondary_id>EudraCT number 2008-005715-18</secondary_id>
    <nct_id>NCT00749307</nct_id>
  </id_info>
  <brief_title>Effects of Docosahexaenoic Acid (DHA) on Heart Rate Variability in Elderly Patients</brief_title>
  <official_title>Effects of Supplementation With Algal Triacylglycerols Versus Placebo on Heart Rate Variability in Elderly Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Campus Bio-Medico University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>IRCCS San Raffaele</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>DSM Nutritional Products, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Pharmanutra s.r.l.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Campus Bio-Medico University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test the hypothesis that dietary supplementation with an
      algal source of docosahexaenoic acid (DHA) can improve the heart rate variability in elderly
      patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In western countries, sudden cardiac death (SCD) represents the most common form of
      cardiovascular death. SCD is often caused by ventricular arrhythmias in patients with a known
      history of ischemic heart disease but it may also occurs in healthy persons.

      In the last years has been extensively studied the protective role of long-chain n-3
      polyunsaturated fatty acids (n-3 LCPUFA) against SCD both in healthy persons and in patients
      affected by coronary artery disease.

      The hypothesis that these evidences could be ascribed to an antiarrhythmic effect of n-3
      LCPUFA, has been corroborated by the observation of a direct relationship between the dietary
      intake of these nutrients and a better cardiac autonomic control.

      This pathway, in particular, has been confirmed by the analysis of changes in heart rate
      variability.

      Most studies in this field used n-3 LCPUFA derived from fish oil, composed by a combination
      of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). At our knowledge there are few
      studies available evaluating the isolated role of DHA, derived from alternative sources of
      n-3 LCPUFA, as the microalgae, in the prevention of fatal arrhythmias.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2008</start_date>
  <completion_date type="Actual">November 2009</completion_date>
  <primary_completion_date type="Actual">September 2009</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Heart rate variability (HRV)</measure>
    <time_frame>basal - 12 weeks - 30 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Arrhythmia</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Docosahexaenoic acid (DHA)</intervention_name>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age above 65 years

        Exclusion Criteria:

          -  Treatment with or allergy to polyunsaturated fatty acids

          -  Diagnosis of arrhythmia or antiarrhythmic therapy

          -  Anticoagulant therapy (except acetylsalicylic acid)

          -  Pacemaker

          -  Bleeding diathesis

          -  Recent cerebral hemorrhage (less than 6 months)

          -  Thyroid dysfunction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raffaele Antonelli Incalzi, MD</last_name>
    <role>Study Director</role>
    <affiliation>Campus Bio-Medico University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Giuseppe Rosano, MD</last_name>
    <role>Study Director</role>
    <affiliation>IRCCS San Raffaele Pisana. Department of Medical Sciences. Cardiovascular Research Unit.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Francesco M Serino, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Campus Bio-Medico University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marco Miceli, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IRCCS San Raffaele Pisana. Department of Sciences. Cardiovascular Research Unit.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>IRCCS San Raffaele Pisana. Department of Medical Sciences. Cardiovascular Research Unit.</name>
      <address>
        <city>Rome</city>
        <state>RM</state>
        <zip>00163</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>November 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 8, 2008</study_first_submitted>
  <study_first_submitted_qc>September 8, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 9, 2008</study_first_posted>
  <last_update_submitted>November 24, 2009</last_update_submitted>
  <last_update_submitted_qc>November 24, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 25, 2009</last_update_posted>
  <responsible_party>
    <name_title>Francesco Maria Serino</name_title>
    <organization>Campus Bio-Medico University</organization>
  </responsible_party>
  <keyword>Heart rate variability</keyword>
  <keyword>Docosahexaenoic acid</keyword>
  <keyword>DHA</keyword>
  <keyword>Long chain fatty acids</keyword>
  <keyword>Long chain polyunsaturated fatty acids</keyword>
  <keyword>Algal fatty acids</keyword>
  <keyword>Schizochytrium</keyword>
  <keyword>Omega 3</keyword>
  <keyword>Death, Sudden, Cardiac</keyword>
  <keyword>Arrhythmias, Cardiac</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

